Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Always Active

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Dr. Ferran Sanz

Co-Founder & Advisor

Ferran Sanz is chemical engineer by the Institut Quimic de Sarrià (Barcelona) and PhD by the Universitat Autònoma de Barcelona. He is Professor of Biostatistics and Biomedical Informatics at Universitat Pompeu Fabra (UPF), scientific staff of the Hospital del Mar Medical Research Institute (IMIM) and Director of the IMIM-UPF Research Programme on Biomedical Informatics (GRIB) since 1985. Dr. Sanz is the author of more than 150 articles and supervisor of 20 PhD theses.

He is the international coordinator of 10 EU-funded initiatives and a STOA report for the European Parliament. Currently, he is the academic coordinator of an IMI (Innovative Medicines Initiative) project on the in silico prediction of drug toxicity (eTRANSAFE). He is also a partner in other ongoing IMI projects (TransQST and FAIRplus) and H2020 projects (EU-ToxRisk and FAIRplus). Chair of the ELIXIR Board, co-president of the Spanish Technology Platform on Innovative Medicines (PTEMI) and vice-president of Bioinformatics Barcelona Association (BIB).